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Abstract The cystic ﬁbrosis transmembrane conductance
regulator (CFTR) Cl
- channels are constitutively activated
in sweat ducts. Since phosphorylation-dependent and -
independent mechanisms can activate CFTR, we sought to
determine the actual mechanism responsible for constitu-
tive activation of these channels in vivo. We show that the
constitutively activated CFTR Cl
- conductance (gCFTR)
in the apical membrane is completely deactivated follow-
ing a-toxin permeabilization of the basolateral membrane.
We investigated whether such inhibition of gCFTR fol-
lowing permeabilization is due to the loss of cytoplasmic
glutamate or due to dephosphorylation of CFTR by an
endogenous phosphatase in the absence of kinase activity
(due to the loss of kinase agonist cAMP, cGMP or GTP
through a-toxin pores). In order to distinguish between
these two possibilities, we examined the effect of inhibiting
the endogenous phosphatase activity with okadaic acid
(10
-8 M) on the permeabilization-induced deactivation of
gCFTR. We show that okadaic acid (1) inhibits an
endogenous phosphatase responsible for dephosphorylating
cAMP but not cGMP or G protein-activated CFTR and (2)
prevents deactivation of CFTR following permeabilization
of the basolateral membrane. These results indicate that
distinctly different phosphatases may be responsible for
dephosphorylating different kinase-speciﬁc sites on CFTR.
We conclude that the phosphorylation by PKA alone
appears to be primarily responsible for constitutive acti-
vation of gCFTR in vivo.
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PKA  PKG  G proteins  Glutamate  a-toxin 
Okadaic acid
Introduction
Generally, epithelial ion channels are thought to be acti-
vated by neurohumoral stimuli in response to electrolyte
transport demand but to remain inactive in the absence of
such stimuli. In contrast, however, the cystic ﬁbrosis
transmembrane conductance regulator (CFTR) Cl
- chan-
nels are constitutively activated in the native human sweat
ducts in the complete absence of neurohumoral stimuli
(Quinton and Reddy 1994; Reddy and Quinton 1992). The
intracellular mediators and mechanism(s) underlying this
phenomenon of constitutive activation of gCFTR are
unknown.
CFTR is very unique among ion channels with respect to
multiple regulatory controls that may involve PKC (Berger
et al. 1993; Jia et al. 1997), PKA (Cheng et al. 1991;
Dulhanty and Riordan 1994), PKG (French et al. 1995;
Picciotto et al. 1992; Vaandrager et al. 1996, 1998), Ca
2?
calmodulin-dependent protein kinases (Picciotto et al.
1992), protein tyrosine kinases (Gadsby and Nairn 1999)
and different protein phosphatases (Berger et al. 1993;
Fischer et al. 1998; Gadsby and Nairn 1999; Luo et al.
1998). Even though these studies implicate several kinases
and phosphatases in regulating CFTR, we do not know
which of these regulatory processes are tissue-speciﬁc or
whether different mechanisms control CFTR within most
epithelial cells. We have previously shown that the CFTR
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activated by phosphorylation-dependent (mediated by
cAMP, cGMP and heterotrimeric G protein-dependent
kinases) and phosphorylation-independent (mediated by
cytoplasmic glutamate and its metabolites) mechanisms
(Quinton and Reddy 1991, 1992; Reddy and Quinton 1994,
2001, 2003, 2005a, 2006). The objective of this study was
to determine which of these regulatory mechanisms is
primarily responsible for constitutive activation of CFTR
Cl
- channels in vivo.
We used basolaterally a-toxin-permeabilized sweat duct
as a model system to investigate the endogenous mecha-
nism(s) involved in the constitutive activation of gCFTR.
We have previously reported that a-toxin permeabilization
of the basolateral membrane causes a gradual decrease in
transepithelial electrical conductance due to the loss of
gCFTR, which in permeabilized ducts could be reactivated
either by exogenous stimulation by adding back cAMP,
cGMP or GTP-c-S in the presence of ATP or by application
of glutamate (or its metabolite a-ketoglutarate or glutamine)
(Quinton and Reddy 1991, 1992; Reddy and Quinton 1994,
2001, 2003, 2005a, 2006). These observations suggest that
the deactivation of constitutively activated gCFTR could be
due to the loss of any of these putative intracellular agonists
in vivo. That is, inhibition of gCFTR following a-toxin
permeabilization could be either due to cytosolic loss of
cyclic nucleotides that mediate different kinases responsible
for phosphorylating CFTR or due to loss of glutamate (or its
metabolites), which is known to stimulate CFTR by a
mechanism that is independent of phosphorylation. Earlier
studies also indicated that while phosphorylation activation
of CFTR required physiological concentration of ATP
(5 mM), glutamate activation of gCFTR is independent of
ATP (Reddy and Quinton 2003) and that inhibiting ATP
production by metabolic poisoning with carbonyl cyanide
m-chlorophenylhydrazone (CCCP) and 2-deoxyglucose (2-
DG) caused spontaneous deactivation of the constitutively
activated CFTR in the intact, nonpermeabilized sweat duct
(Quinton and Reddy 1992). These early data suggested that
the constitutive activation of CFTR in this tissue may
involve an ATP-dependent phosphorylation process rather
than a phosphorylation-independent, glutamate-mediated
mechanism. Based on these observations, we sought to test
the hypothesis that endogenous phosphorylation of CFTR is
responsible for constitutive activation of gCFTR in vivo.
We tested the hypothesis by determining the effects of
inhibiting endogenous phosphatase activity on the deacti-
vation of gCFTR that follows a-toxin permeabilization of
thebasolateralmembrane. Therationalebehindthisstrategy
was that if CFTR is dephosphorylated by endogenous
phosphataseintheabsenceofkinasestimulation (duetoloss
of cAMP, cGMP or GTP through a-toxin pores), we should
be able to prevent deactivation by inhibiting the okadaic
acid-sensitive endogenous phosphatase that prevents
dephosphorylation of PKA-activated CFTR (Reddy and
Quinton 1996). On the other hand, if constitutive CFTR
activation is due to cytoplasmic levels of glutamate (or its
precursors), okadaic acid should not prevent CFTR run-
down during and after permeabilization with a-toxin. We
show that inhibiting endogenous phosphatase activity with
okadaic acid before permeabilization virtually abolished a-
toxin-induced deactivation of CFTR so long as ATP was
present in the cytoplasmic bath. We conclude that consti-
tutive activation of gCFTR in this tissue results from per-
sistent phosphorylation of CFTR by a kinase whose activity
exceeds that of an okadaic acid-sensitive phosphatase,
probably protein phosphatase 2A (PP2A), which appears to
be responsible for dephosphorylating this channel (Reddy
and Quinton 2006).
Methods
Tissue Acquisition
Sweat glands were obtained from adult male volunteers
who gave informed consent. Full-thickness skin biopsies
(3 mm diameter) were taken over the scapula and stored in
Ringer solution. Individual sweat glands were isolated
from the biopsy in cold Ringer solution by dissection with
ﬁne-tipped tweezers visualized at 980 magniﬁcation. The
isolated glands were transferred to a dissection cuvette with
Ringer solution cooled with a peltier block to 4C where
the segments of reabsorptive duct ([1 mm in length) were
separated from the secretory coil of the sweat gland. The
sweat duct was transferred to a perfusion chamber con-
taining Ringer solution at 35 ± 2C.
Selective Permeabilization of the Basolateral
Membrane
The basolateral membrane of the sweat duct was selectively
permeabilized with the pore-forming agent a-toxin (1,000
units/ml)incytoplasmicRingersolutioncontaining140 mM
KGlu (potassium gluconate) and 5 mM ATP. a-Toxin was
appliedtothebasolateralsurfaceofthemicroperfusedsweat
ductfor15–30 min.a-Toxinformsporesthatpassmolecules
of 3,500–5,000 mwu (Quinton and Reddy 1992) so that the
concentration of intracellular molecules such as cAMP and
ATP as well as pHi can be clamped by their concentration in
the extracellular bath solution.
Electrical Measurements
After cannulating the lumen of the sweat duct with a
double lumen cannula made from theta glass (1.5 mm
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UK), a constant current pulse of 50–100 nA for a duration
of 0.5 s was injected through one barrel of the cannulating
pipette containing NaCl Ringer solution. The other barrel
of the cannulating pipette served as an electrode for mea-
suring transepithelial potential (Vt) with respect to the
contraluminal bath and as a cannula for perfusing the
lumen of the duct with selected solutions. Vt was monitored
continuously using one channel of a WPI-700 dual elec-
trometer (Sarasota, FL, USA) referenced to the contralu-
minal bath. Since the sweat duct is a tubular epithelium
whose lumen is a conductive core surrounded by an insu-
lating epithelium, we measured the transepithelial speciﬁc
conductance (Gt) as described earlier from the amplitude of
transepithelial voltage deﬂections in response to transepi-
thelial constant current pulse using a cable equation (Gre-
ger 1981; Helman et al. 1971; Quinton and Reddy 1992;
Reddy, Light and Quinton 1999). Our general experimental
protocol was to ﬁrst allow spontaneous deactivation of
CFTR and perifuse the cytosol with K
? or Na
? gluconate
while perfusing the lumen with NaCl Ringer solution.
Epithelial Na
? channels (ENaCs) were always blocked by
amiloride (10
-5 M). The integrity of the tissue was ﬁrst
conﬁrmed by a large increase in CFTR Cl
- conductance
(gCFTR) following the application of cAMP and ATP as
shown (Fig. 1).
CFTR Cl
- conductance (gCFTR) in ducts after inhib-
iting ENaC conductance with luminal amiloride was cal-
culated using the following formula: Gt = gCFTR ? gX,
where Gt is total transepithelial conductance after stimu-
lating gCFTR (with agonists such as cAMP, cGMP, G
proteins or glutamate in the cytoplasmic bath) and gX is a
nonspeciﬁc shunt conductance measured after blocking
gENaC (with luminal amiloride) and gCFTR (by removing
CFTR agonists from cytoplasmic bath). The aforemen-
tioned formula used to calculate the magnitude of gCFTR
is based on the fact that CFTR and ENaC provide the
predominant (probably only) Cl
- and Na
? conductance
pathways in this tissue (Quinton 1986; Reddy and Quinton
1994).
Solutions
The luminal perfusion Ringer solutions contained (in mM)
NaCl, KCl or KHCO3
- (150); K
? (5); PO4 (3.5); MgSO4
(1.2); and Ca
2? (1) (pH. 7.4). Cl
- free luminal Ringer
solution was prepared by complete substitution of Cl
- with
the impermeant anion gluconate. The cytoplasmic/bath
solution contained (in mM) K
? (145), gluconate (140), PO4
(3.5), MgSO4 (1.2) and 260 lMC a
2? buffered with
2.0 mM EGTA (Sigma, St. Louis, MO) to 80 nM free Ca
2?
(pH 6.8). K
? ATP (0.01–5 mM), cAMP (0.1 mM), cGMP
Fig. 1 Effect of a-toxin and cAMP on transepithelial electrical
properties. a A representative electrical trace showing the effect of
permeabilization of basolateral membrane with a-toxin. In this
experiment, lumen and bath were perfused with 150 mM NaCl and
140 mM KGlu ? 5 mM ATP, respectively. The amiloride-sensitive
ENaCs in the apical membrane were blocked by amiloride. Under
these conditions, the lumen positive transepithelial potential and
conductance predominantly reﬂect Cl
- conductance. Notice that a-
toxin permeabilization caused progressive loss of transepithelial
electrical conductance and lumen positive electrical potential. Hence,
the experimental changes in the electrical properties induced by a-
toxin permeabilization of the basolateral membrane primarily reﬂect
loss of CFTR Cl
- conductance, which is the predominant Cl
- channel
in this native tissue, as previously mentioned. The a-toxin-induced
deactivation of transepithelial Cl
- conductance is reactivated by the
addition of the CFTR agonist cAMP in the presence of a physiolog-
ical concentration of ATP. b Summary of similar experiments as
shown in a. Notice that a-toxin-induced deactivation of Cl
-
conductance is fully restored following application of cAMP ? ATP
in the cytoplasmic bath. (C) and (L) represent cytosolic bath and
lumen, respectively. The data reﬂect mean ± SE. * Signiﬁcantly
different from values before application of a-toxin and after
application of a-toxin ? cAMP: P[0.001
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123(0.1 mM), GTP-c-S (0.1 mM), glutamate (10 mM) or a-
ketoglutarate (1 mM) was added to the cytoplasmic bath as
needed. Endogenous phosphatases were inhibited by add-
ing okadaic acid (10
-8 M) to the cytoplasmic bath either
before or after permeabilization as needed.
Data Analysis
The data are presented as the mean ± SE (where n is the
number of ducts from at least four human subjects). Sta-
tistical signiﬁcance was determined on the basis of Stu-
dent’s t-test for paired samples. P\0.05 was chosen to
indicate a statistically signiﬁcant difference. The data
presented as electrophysiological traces are representative
of experiments repeated at least three times.
Results
Effect of a-Toxin Permeabilization
Lumen to Cell Cl
- Gradients
Sweat ducts from non-CF subjects were initially perfused
with 150 mM NaCl in the bath and 150 mM
NaCl ? 10
-5 M amiloride in the lumen. The bath perfus-
ate was changed to 140 mM KGlu ? 5 mM ATP before
the application of a-toxin in the bath. Before the applica-
tion of a-toxin, the sweat ducts were perifused with
140 mM KGlu ? 5 mM ATP in the bath and perfused with
150 mM NaCl ? amiloride (to block ENaCs). This
maneuver caused a large depolarization of transepithelial
potential that reﬂects predominant Cl
- conductance in this
tissue. During the initial phase of pore formation lasting for
about 1–2 min, application of a-toxin in the presence of
140 mM KGlu ? 5 mM ATP in the basolateral bath
compartment caused a small decline (or no change) in
transepithelial conductance (pre-a-toxin Gt = 33 ± 4 mS/
cm
2) and potential (pre-a-toxin VCl = 45 ± 5m V).
Thereafter, a gradual decline occurred in both Gt (to the
level of the nonspeciﬁc leak conductance Gx, which is
about 5 ± 3 mS/cm
2) and Vt (to the level of the junction
potential, which is about 10 ± 4m V, n = number of ducts
from at least four human subjects) in *15 min after the
application of a-toxin (Fig. 1).
No Cl
- Gradient
Application of a-toxin in the absence of Cl
- in the lumen
and cytoplasmic bath had little effect on Vt (13 ± 3 vs.
12 ± 4m V) and Gt (8 ± 5 and 4 ± 6 mS/cm
2) before and
after application of a-toxin, respectively. The Vt and Gt in
the absence of Cl
- in the lumen and cytoplasmic bath
reﬂect a nonspeciﬁc leak conductance because the only
remaining apical ENaC conductance was blocked with
amiloride in the lumen (Fig. 2).
Sweat Ducts from DF508/DF508 CF Subjects
Sweat ducts from homozygous (DF508/DF508) or hetero-
zygous (DF508/R117H) CF subjects were initially perfused
with 150 mM NaCl in the bath and 150 mM
NaCl ? amiloride in the lumen. Before the application of
a-toxin, the bath perfusate was changed from 150 mM
NaCl to 140 mM KGlu ? 5 mM ATP (as described above
for non-CF ducts). In contrast to the response of non-CF
ducts, this maneuver caused very small depolarization of
transepithelial potential in ducts from homozygous DF508/
DF508 CF patients (mostly reﬂects junction potential).
Application of a-toxin in the bath did not change the Vt or
Gt in these ducts (Fig. 3a).
Sweat Ducts from R117H/DF508 CF Subjects
We noticed signiﬁcant depolarization of transepithelial
potential of heterozygous (DF508/R117H) CF ducts when
bath NaCl was replaced with KGlu (Fig. 3b), although the
magnitude of depolarization of these compound heterozy-
gous CF ducts was relatively smaller compared to that of
normal ducts (Figs. 1a, 3b). In contrast to the lack of
electrical response of DF508 homozygous CF ducts, the
application of a-toxin induced qualitatively similar elec-
trical responses in heterozygous (DF508/R117H, i.e.,
gradual increase in transepithelial resistance corresponding
with pore formation and loss of intracellular messengers)
as observed in normal ducts (Figs. 1a, 3b).
a-Toxin-Induced Deactivation of CFTR
Effect of Okadaic Acid
Pretreatment of sweat duct with okadaic acid (10
-8 M)
prevented deactivation of constitutively activated gCFTR
following permeabilization of the basolateral membrane
with a-toxin. This is indicated by the fact that the VCl
(48 ± 6m V) and gCl (37 ± 4 mS/cm
2) remained virtually
unaffected by permeabilization so long as ATP was present
in the cytoplasmic bath (Fig. 4).
Effect of Glutamate
a-Toxin failed to deactivate gCFTR when applied in the
presence of glutamate or its metabolite a-ketoglutarate. The
transepithelial potential and conductance remained high as
long as glutamate or its metabolite a-ketoglutarate remained
inthecytoplasmicbath(Fig. 5a).Incomparison,application
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vatedgCFTR inthe absenceofglutamateasindicated by the
reduction of transepithelial potential to the values repre-
senting the junction potentials (VCl = 9 ± 4m V) and
leak conductance (gCl = 5 ± 3 mS/cm
2), respectively.
Addition of glutamate alone (no ATP) restored gCFTR
(VCl = 62 ± 8m V and gCl = 37 ± 5 mS/cm
2, n = 8)
(Fig. 5b, c).
Fig. 2 Lack of effect of a-toxin on the electrical properties of sweat
duct in the absence of Cl
-. a A representative electrical trace showing
effect of a-toxin in the complete absence of Cl
- in the lumen and
bath. In this experiment a-toxin was applied after replacing the
luminal Cl
- with impermeant anion gluconate. Notice that replacing
luminal Cl
- with gluconate has a qualitatively similar effect as that
induced by a-toxin (i.e., loss of transepithelial electrical conductance
and lumen positive electrical potential). These results further
indicated that a-toxin permeabilization inhibited apical CFTR Cl
-
conductance. Activation of CFTR Cl
- conductance was indicated by
the changes in the amplitude of transepithelial current pulse indicated
by downward voltage deﬂections and the lumen positive transepithe-
lial Cl
- diffusion potential induced by 150 mM Cl
- in the lumen and
140 mM impermeant anion gluconate (Glu) in the bath. b Summary
of the results obtained from similar experiments as shown in a. Notice
that transepithelial potential and conductance were signiﬁcantly
reduced in the absence of Cl
-, which did not decrease any further
following application of a-toxin. (C) and (L) represent cytosolic bath
and lumen, respectively. * Signiﬁcantly different from corresponding
values in the presence of luminal Cl
- before application of a-toxin:
P[0.001
Fig. 3 a Effect of a-toxin on the transepithelial potential and
conductance in DF508 homozygous CF ducts. In this experiment
the lumen was perfused with 150 mM NaCl ? amiloride and the bath
was perifused with 140 mM KGlu ? 5 mM ATP before a-toxin
application. Notice that there is a signiﬁcantly smaller depolarization
of transepithelial potential, reﬂecting absence of CFTR in the plasma
membranes of this tissue. In contrast to the non-CF ducts, application
of a-toxin had little effect either on the transepithelial potential or on
the conductance. b In contrast to the homozygous CF ducts,
heterozygous CF ducts with R117H/DF508 mutations showed a small
but consistent depolarization to the imposed Cl
- gradient. In addition,
application of a-toxin resulted in a qualitatively similar response
(abolition of transepithelial potential and conductance) as in normal
ducts, but the magnitude of response was signiﬁcantly smaller. These
results are consistent with the fact that R117H CF mutation retains
residual Cl
- conductance. (C) and (L) represent cytosolic bath and
lumen, respectively
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a-Toxin-deactivated gCFTR could be reactivated via het-
erotrimeric G proteins in the apical membrane activated
with 100 lM GTP-c-S and 5 mM ATP in the cytoplasmic
bath as shown by the fact that the post-a-toxin-treated
values of Vt (9.0 ± 4m V) and Gt (4 ± 3 mS/cm
2) were
restored to values comparable to those obtained after
stimulating with cAMP ? ATP or glutamate (Fig. 6a).
That is, the VCl (50 ± 5m V) and gCl (39 ± 8 mS/cm
2)
after stimulating with 100 lM GTP-c-S in the presence of
5 mM ATP were comparable to those observed in the
presence of cAMP ? ATP or glutamate (Fig. 6a).
Okadaic Acid
Blocks Dephosphorylation of PKA-Activated CFTR
We have previously shown that depletion of cytosolic K
?
during transcellular Na
? absorption causes progressive
dephosphorylation deactivation of CFTR (Reddy and
Quinton 2006). K
? depletion (cytosolic K
? substituted
with Na
?)-induced deactivation of CFTR was prevented by
the application of okadaic acid (10
-8 M), an inhibitor of
PP2A. Figures 6b and 7 show that inhibiting endogenous
okadaic acid-sensitive phosphatase prevents K
? substitu-
tion-induced deactivation of cAMP-activated CFTR.
Does Not Block Dephosphorylation of G Protein-Activated
CFTR
In contrast to the effect of okadaic acid on PKA-activated
gCFTR, G protein-activated gCFTR remained sensitive to
cytosolic changes in K
? activity even in the presence of
okadaic acid. That is, gCFTR was acutely inhibited by
substituting cytoplasmic K
? with Na
? regardless of the
presence or absence of okadaic acid and hence the PP2A
activity (Figs. 6c, 7).
Does Not Block Dephosphorylation of cGMP-Activated
CFTR
cGMP activated gCFTR in only about 45% of the ducts
tested (n = 23). The magnitude of activation of gCFTR by
cGMP in those responsive ducts varied 5–100% of the
magnitudeofcAMP-activatedgCFTR(Fig. 8).Incontrastto
the effect of okadaic acid on PKA-activated gCFTR, the
cGMP-activated gCFTR remained sensitive to cytosolic
changes in K
? activity even in the presence of okadaic acid.
That is, gCFTR was acutely inhibited by substituting cyto-
plasmic K
? with Na
? regardless of the presence or absence
of okadaic acid and hence the PP2A activity (Fig. 9).
Fig. 4 Effect of okadaic acid on a-toxin-induced deactivation of
gCFTR. a A representative electrical trace showing the effect of
PP2A inhibitor okadaic acid on the a-toxin-induced deactivation of
gCFTR. This experiment was designed to test the hypothesis that
deactivation of CFTR Cl
- conductance following a-toxin permeabi-
lization of the basolateral membrane is due to uninterrupted
phosphatase dephosphorylation of CFTR in the absence of PKA
phosphorylation activity (due to loss of cAMP through a-toxin pores).
Hence, inhibiting the endogenous phosphatase responsible for
dephosphorylating CFTR should prevent deactivation of CFTR Cl
-
conductance following a-toxin permeabilization. Notice that, consis-
tent with this hypothesis, prior inhibition of phosphatase (most likely
PP2A) with okadaic acid prevented CFTR deactivation after appli-
cation of a-toxin. CFTR remained activated as long as ATP was
present in the cytoplasmic bath. b Summary of the data from similar
experiments as shown in a. (C) and (L) represent cytosolic bath and
lumen, respectively. The data indicate mean ± SE. Notice that after
treating the duct with okadaic acid, a-toxin failed to deactivate CFTR-
Cl
- conductance
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CFTR Cl
- Conductance Is Constitutively Activated in
the Human Sweat Duct
gCFTR appears fully activated in *75% of human sweat
ducts under basal conditions (Fig. 8c). We have previously
shown that no additional activation of gCFTR occurs upon
exogenous stimulation by CFTR agonists such as the b-
adrenergic agonist isoproterenol (IPR), permeable ana-
logue of cAMP (CPT-cAMP) or activator of adenylate
cyclase (forskolin), phosphodiesterase inhibitor (IBMX)
and PGE2 (before or after inhibition of cyclooxygenase
with indomethacin) (Reddy and Quinton 1992). Even in
ducts that responded to CFTR agonists, the response was
marginal so that the additional stimulus was[15% of the
maximal activated gCFTR, suggesting that *85% of the
gCFTR was activated in 100% of the ducts tested for
agonist response (Reddy and Quinton 1992). This phe-
nomenon of constitutive activation of CFTR is not conﬁned
to sweat ducts alone but is also observed in other epithelial
cells such as Calu-3 cells (Moon et al. 1997; Shen et al.
1994), pig trachea (unpublished personal observation) and
small airways (Wang et al. 2005). The mechanisms of
regulating CFTR can be broadly classiﬁed as those which
involve phosphorylation and ATP and those that appear
independent of phosphorylation and ATP. The ﬁrst cate-
gory includes multiple intracellular mediators such as
cAMP (Berger et al. 1993; Cheng et al. 1991; Dulhanty and
Riordan 1994), cGMP (French et al. 1995; Picciotto et al.
1992; Vaandrager et al. 1996, 1998), PKC (Berger et al.
1993; Jia et al. 1997), G proteins (Reddy and Quinton
2004; Reddy et al. 2001) and Ca
2? calmodulin kinase
(Picciotto et al. 1992), not only in sweat ducts but also in
Fig. 5 Effect of glutamate on a-toxin-induced deactivation of CFTR.
a A representative electrical trace showing the effect of glutamate on
a-toxin-induced deactivation of gCFTR. Notice that the transepithe-
lial conductance and Cl
- diffusion potentials remained relatively
unaffected by a-toxin permeabilization in the presence of 1 mM a-
ketoglutarate in the cytosol. b In comparison to the lack of effect of a-
toxin as shown in a, a-toxin permeabilization spontaneously
decreased transepithelial Cl
- conductance and diffusion potential in
the absence of glutamate or its metabolite, which could be reversed
immediately following application of 1 mM a-ketoglutarate in the
cytosolic bath. c Summary of the results from similar experiments as
shown in a and b. Notice that the cytosolic glutamate or its metabolite
caused activation of gCFTR that is almost similar in magnitude. The
presence of glutamate prevents a-toxin-induced deactivation of CFTR
in the complete absence of ATP in the cytosol, indicating that
glutamate activation of CFTR is independent of phosphorylation,
as previously reported (Reddy and Quinton 2003). (C) and (L)
represent cytosolic bath and lumen, respectively. The data represent
mean ± SE
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systems. The second category involves the recently
described phosphorylation and ATP-independent mecha-
nism mediated by cytosolic glutamate (or its metabolites a-
ketoglutarate and glutamine) in the human sweat duct
(Reddy and Quinton 2003). In light of these observations,
the question arises as to which one of these mechanisms
(phosphorylation-dependent or phosphorylation-indepen-
dent) is responsible for keeping CFTR Cl
- channels con-
stitutively activated in vivo. We addressed this issue by
ﬁrst changing the deactivated state of CFTR from its
constitutively activated state by depleting the putative
cytosolic mediators that are suspected of being involved in
the channel activation in vivo and then systematically
examining which intracellular messenger might mediate
the basal channel activity.
How Does CFTR Change to a Deactivated State?
In the absence of a clear understanding of which agonist is
actually responsible for constitutively activating CFTR, it
is difﬁcult to predict the mechanisms involved in its
deactivation. Early attempts to deactivate CFTR by inhib-
iting b-adrenergic receptors with the antagonist proprano-
lol or the cyclooxygenase inhibitor indomethacin were
unsuccessful (Quinton and Reddy 1991; Reddy and Quin-
ton 1992). These results suggested either that (1) cAMP
may not be the physiological agonist, (2) these maneuvers
failed to signiﬁcantly reduce intracellular cAMP levels due
to weak phosphodiesterase activity, (3) weak endogenous
phosphatase activity is responsible for dephosphorylating
CFTR, (4) mechanisms other than cAMP-dependent
phosphorylation may be involved such as cGMP or G
protein-dependent kinase or (5) phosphorylation-indepen-
dent mechanisms (such as glutamate-dependent activation)
may be involved in keeping the CFTR channels constitu-
tively activated. However, initial evidence that phosphor-
ylation-dependent mechanisms may be responsible for the
constitutive activation of CFTR in vivo is provided by the
Fig. 6 Effect of cytosolic monovalent cations on phosphatase
dephosphorylation of CFTR. a A representative electrical trace
showing the effect of K
? substitution with Na
? on cAMP and G
protein-activated CFTR. These experiments show that phosphoryla-
tion activation of CFTR-Cl
- conductance by cAMP and G proteins is
sensitive to changes in cytosolic monovalent cation composition. That
is, replacing cytosolic K
? with Na
? promptly deactivates gCFTR
regardless of the mode of stimulation by cAMP or G proteins. G
proteins are stimulated by GTP-c-S. b A representative experiment
showing the effect of cytoplasmic K
? substitution by Na
? on cAMP-
activated CFTR after application of PP2A inhibitor okadaic acid.
Notice that, unlike in Fig. 5a, cAMP can activate CFTR even after
complete K
? substitution with Na
? after inhibiting endogenous PP2A
with okadaic acid. These results show that okadaic acid-sensitive
phosphatase dephosphorylates cAMP-phosphorylated CFTR as previ-
ously reported. c A representative experiment showing the effect of
cytoplasmic K
? substitution by Na
? on G protein-activated CFTR
after application of the PP2A inhibitor okadaic acid. Notice that,
unlike cAMP, G protein activation with GTP-c-S failed to stimulate
CFTR after complete K
? substitution with Na
? even in the presence
of okadaic acid. These results show that G protein-activated CFTR is
dephosphorylated by an okadaic acid-insensitive phosphatase. (C) and
(L) represent cytosolic bath and lumen, respectively
Fig. 7 Effect of okadaic acid on cAMP and G protein-activated
gCFTR. Summary of the results from similar experiments as shown in
Fig. 5. The data represent mean ± SE. * Signiﬁcant difference from
respective control values: P[0.001
72 M. M. Reddy, P. M. Quinton: CAMP Mediates Basal CFTR Activity in Sweat Duct
123observation that the large transepithelial Cl
- conductance
of sweat duct is completely abolished following depletion
of ATP by metabolic poisoning with CCCP and 2-DG
(Quinton and Reddy 1992). ATP is an essential substrate in
phosphorylation reactions besides being required for gating
CFTR ion channels. Furthermore, glutamate stimulation of
CFTR is independent of ATP. Therefore, the inhibitory
effect of metabolic poisoning on gCFTR formed the basis
of our hypothesis that endogenous kinase phosphorylation
constitutively stimulates CFTR in sweat duct. We used a-
toxin-permeabilized sweat duct model to investigate this
hypothesis based on the following rationale.
a-Toxin Permeabilization Causes Complete
Deactivation of CFTR
As previously reported, human sweat ducts predominantly
express CFTR-Cl
- conductance (Quinton 1986; Reddy and
Quinton 1992) and [80% of the transepithelial ion con-
ductance is mediated by CFTR (Quinton 1986). After
inhibiting the epithelial Na
? conductance with amiloride,
the apical membrane becomes almost exclusively
Cl
—selective, with minimal nonselective shunt conduc-
tance. The presence of 140 mM KGlu ? 5 mM ATP (to
partially mimic cytosolic conditions) in the bath and
150 mM NaCl ? amiloride in the lumen causes a
signiﬁcant lumen positive Cl
- diffusion potential (Fig. 1).
Following permeabilization of the basolateral membrane
with a-toxin, the lumen positive potential gradually
decreased to a value of about ?11 mV (which is almost
identical to the liquid junction potential) while simulta-
neously decreasing the transepithelial conductance to a
value taken as a nonspeciﬁc shunt conductance (Fig. 1).
The following observations indicate that a-toxin perme-
abilization of the basolateral membrane effectively deacti-
vated gCFTR without causing signiﬁcant damage to the
apical membrane or the cytosolic macromolecular regula-
tory components such as kinases and phosphatases. First,
substituting luminal Cl
- with an impermeable anion gluco-
nate (complete absence of Cl
- in the basolateral side as well
asluminalside)abolishedlumenpositivepotential,asoccurs
following a-toxin permeabilization (Fig. 2). Second, appli-
cation of a-toxin in the complete absence of Cl
- did not
signiﬁcantly decrease transepithelial conductance, indicat-
ingthatthedecreaseinelectricalconductanceinthepresence
of luminal Cl
- is in fact due to decreased Cl
- conductance.
Third, application of a known CFTR agonist, cAMP,
restored Cl
- diffusion potential and conductance (Fig. 1),
whichwascompletelyinhibitedbytheCFTRblockerCFTR-
Inh172 (Reddy and Quinton 2002). Fourth, Cl
- diffusion
potential was either completely absent (in homozygous
DF508 CF ducts that lack CFTR activity) (Quinton 1986)
Fig. 8 Inconsistent cGMP
regulation of CFTR. Unlike
cAMP and G proteins, cGMP
activation of CFTR is labile.
The magnitude of activation of
CFTR in sweat duct varied
between the ducts and even
within the same duct as a
function of time. In some
freshly isolated ducts the
magnitude of cGMP activation
of CFTR was comparable to that
of cAMP (as shown in a),
whereas in some other ducts the
response is completely absent
(as shown in b). cGMP
stimulated gCFTR only in
*45% of the ducts, while
cAMP and G proteins
stimulated CFTR in almost
100% of the sweat ducts (c). (C)
and (L) represent cytosolic bath
and lumen, respectively
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DF508 CFductsthatpartiallyexpressCFTRactivity)(Reddy
and Quinton 2003)( F i g . 3b) compared to non-CF ducts
(Fig. 1). Furthermore, permeabilization of the basolateral
membrane with a-toxin either had no effect in homozygous
DF508 CF ducts (Fig. 3a) or had qualitatively similar but
quantitatively smaller effects on transepithelial potential or
conductance of R117H/DF508 CF ducts, which is consistent
with reduced gCFTR in these ducts. These results further
support the notion that loss of Cl
- diffusion potentials and
conductancefollowinga-toxinpermeabilizationisinfactdue
to the loss of intracellular mediators that activate CFTR. We
reasoned that a better understanding of the mechanism(s)
underlying a-toxin-induced deactivation of gCFTR may
provide insights to the physiological mechanism responsible
for constitutive activation of CFTR in vivo.
Endogenous Phosphorylation Is Responsible
for Constitutive Activation of CFTR
After establishing the fact that a-toxin permeabilization
causes CFTR deactivation due to loss of intracellular
messengers, we sought to determine whether kinase
phosphorylation or cytosolic glutamate metabolites keep
CFTR constitutively activated. We reasoned that if kinase
phosphorylation is responsible for deactivation of CFTR
following a-toxin permeabilization, preventing dephos-
phorylation of CFTR by inhibiting endogenous phospha-
tase activity before application of a-toxin should prevent
deactivation of the channels following a-toxin permeabi-
lization. We used okadaic acid to inhibit the phosphatase
activity because it was shown to prevent dephosphoryla-
tion deactivation of cAMP-activated CFTR in the human
sweat duct (Reddy and Quinton 1996) and in patch-clamp
studies using heterologous expression systems in which
okadaic acid-sensitive PP2A was shown to prevent
dephosphorylation of the channel (Berger et al. 1993). As
shown in Fig. 4, when endogenous phosphatase activity
was inhibited by okadaic acid, subsequent permeabiliza-
tion of basolateral membrane with a-toxin had little effect
on the transepithelial Cl
- diffusion potential and con-
ductance. gCFTR remained activated as long as ATP was
present in the cytoplasmic bath. If a phosphorylation-
independent, glutamate-dependent mechanism was
involved in constitutive activation of CFTR, we should
have seen spontaneous deactivation of CFTR following a-
toxin application even after inhibiting the phosphatase
activity because permeabilization also allows glutamate to
diffuse in and out of the cytosol through a-toxin pores, as
shown in Fig. 5. These results indicated that constitutive
activation of CFTR is most likely due to persistent
phosphorylation of CFTR by endogenous kinases whose
activity far exceeds that of endogenous okadaic acid-
sensitive phosphatase.
Which Kinase Is Responsible for Constitutive
Activation In Vivo?
We have previously shown that CFTR can be activated by
PKA, PKG and heterotrimeric G protein-dependent kinase
(Reddy et al. 1999). Therefore, the question arises as to
which one of these kinases is responsible for constitutively
activating CFTR. We now know that inhibition of an
endogenous okadaic acid-sensitive PP2A prevents deacti-
vation of CFTR following a-toxin permeabilization.
Therefore, we investigated whether PP2A speciﬁcally
deactivates either PKA, PKG or G protein-phosphorylated
CFTR with the following rationale. If okadaic acid-sensi-
tive phosphatase acts only on PKA but not PKG and G
protein-dependent kinase-phosphorylated CFTR, we can
conclude that PKA is most likely to be the kinase (and not
PKG or G proteins) that phosphorylates CFTR to keep it
constitutively activated in vivo. The following evidence
appears to be consistent with this notion.
Fig. 9 Effect of cytosolic monovalent cations and okadaic acid on
cGMP activation of gCFTR. a A representative electrical trace
showing the effect of K
? substitution with Na
? on cGMP and
activated CFTR. These experiments show that phosphorylation
activation of CFTR-Cl
- conductance by cGMP is sensitive to
changes in cytosolic monovalent cation composition. That is,
replacing cytosolic K
? with Na
? promptly deactivates cGMP-
activated gCFTR. b The data show that okadaic acid has no effect
on the inhibition of gCFTR following cytosolic K
? substitution with
Na
?. These results indicate that, unlike PKA (cAMP)-phosphorylated
CFTR, which is dephosphorylated by okadaic acid-sensitive phos-
phatase (Figs. 5, 6), PKG (cGMP)-phosphorylated CFTR is dephos-
phorylated by an okadaic acid-insensitive phosphatase, which is also
sensitive to cytosolic changes in monovalent cations. (C) and (L)
represent cytosolic bath and lumen, respectively
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for Constitutive Activation of CFTR
We have previously shown that apical heterotrimeric G
proteins activate a cAMP-independent kinase that causes
phosphorylation activation of CFTR in the presence of
ATP in the human sweat duct (Reddy and Quinton 2001;
Reddy et al. 2001). G protein control of CFTR has been
demonstrated in airway epithelial cells (Schwiebert et al.
1992). Stretch-induced stimulation of heterotrimeric G
proteins is well documented (Gudi et al. 1996). Since
luminal ﬂuid ﬂow during physiological sweating or under
microperfusion conditions is expected to stretch the apical
membrane, it seems logical that any activation of G
proteins during luminal perfusion could stimulate CFTR
by G protein-dependent kinase phosphorylation. There-
fore, we examined if the dephosphorylation deactivation
of G protein-activated CFTR is sensitive to okadaic acid
with the following rationale. If constitutive activation of
CFTR is due to activation of heterotrimeric G proteins,
then the endogenous phosphatase responsible for
dephosphorylating and deactivating G protein-activated
CFTR must be inhibited by okadaic acid. Otherwise,
deactivation of CFTR following a-toxin-induced pore
formation cannot be prevented by okadaic acid. We
investigated this question by exploiting the fact that
okadaic acid-sensitive endogenous phosphatases respon-
sible for dephosphorylating CFTR are inhibited by cyto-
solic K
? (Reddy and Quinton 2006). Substituting
cytosolic K
? with Na
? caused signiﬁcant activation of
okadaic acid-sensitive phosphatase activity, resulting in
the dephosphorylation deactivation of CFTR (Reddy and
Quinton 2006). Our results (Figs. 6, 7) show that CFTR
activated by both cAMP and G proteins could be deacti-
vated by substituting K
? in the cytoplasmic bath with
Na
?. However, inhibiting the endogenous phosphatase
with okadaic acid only prevented K
? depletion-induced
deactivation of cAMP-, but not G protein-, activated
CFTR (Fig. 6, 7). These results indicate that two distinctly
different endogenous phosphatases dephosphorylate CFTR
activated by cAMP and the G proteins. That is, cAMP-
dependent protein kinase and the G protein-dependent
kinase must be phosphorylating different sites on CFTR
that are targeted by two different phosphatases, only one
of which is sensitive to okadaic acid. In other words, these
results indicate that (1) different phosphatases are
responsible for dephosphorylating CFTR that had been
phosphorylated by cAMP-dependent kinase (PKA) and G
protein-activated kinase and (2) okadaic acid-sensitive
phosphatase is only responsible for dephosphorylating
PKA-, but not G protein-, phosphorylated CFTR.
cGMP Is Also Not Likely to Support Constitutive
Activation
Even though gCFTR can be activated by cGMP after a-
toxin permeabilization, either a majority of sweat ducts
(55%) did not respond at all or, if they responded, the
magnitude of activation of gCFTR by this agonist was
signiﬁcantly smaller than that of cAMP or G protein ago-
nist GTP-c-S (Fig. 8). In fact, gCFTR could be stimulated
by cGMP only in *45% of the ducts after a-toxin per-
meabilization vs. 100% of the ducts responding to stimu-
lation by cAMP and G protein activation by GTP-c-S after
permeabilization (Fig. 8). These results suggest that PKG
activity is either very weak or absent in a majority of sweat
ducts for reasons that we do not understand at this time. In
contrast, gCFTR is fully activated under basal unstimulated
conditions in *70% of intact ducts. It is therefore unlikely
that the cAMP regulatory pathway, which is only partially
operational in only *45% of the ducts, could be respon-
sible for constitutive activation of CFTR (mostly if not
fully) in almost 100% of the ducts. Hence, loss of cGMP
cannot be responsible for consistent deactivation of CFTR
following a-toxin permeabilization. Preliminary results
also indicated that even in those ducts in which cGMP
could stimulate CFTR as effectively as cAMP (Figs. 8, 9),
application of okadaic acid only prevented dephosphoryl-
ation of cAMP-, but not cGMP-, stimulated CFTR (Fig. 9).
These results indicate that (1) different phosphatases are
responsible for dephosphorylating PKA- and PKG-phos-
phorylated CFTR and (2) okadaic acid-sensitive phospha-
tase is only responsible for dephosphorylating PKA-, but
not PKG-, phosphorylated CFTR.
PKA Phosphorylation Seems to Be Responsible
for Basal CFTR Activity In Vivo
It is now evident that neither G protein- nor PKG-phos-
phorylated CFTR can be dephosphorylated by okadaic
acid-sensitive PP2A. Therefore, inhibiting this phosphatase
with okadaic acid would have no effect on the deactivation
of CFTR following a-toxin permeabilization, had either of
these kinases been responsible for constitutive activation of
CFTR. Furthermore, since glutamate activation of CFTR is
independent of ATP and phosphorylation (Reddy and
Quinton 2003), okadaic acid would not have had any effect
on the a-toxin-induced deactivation of CFTR, had this
agonist been responsible for the constitutive activation of
CFTR in vivo. Therefore, it seems most likely that PKA
phosphorylation controlled by PP2A is responsible for
basal endogenous activation of CFTR in this tissue and
possibly in most other epithelial cells in which PKA
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(Gadsby and Nairn 1999; Schwiebert et al. 1999).
Why Is CFTR Under Multiple Regulatory Controls?
The observation that PKA phosphorylation is responsible
for basal CFTR activity in the human sweat duct raises the
question of whether this is true in other tissues that express
CFTR. cAMP is the predominant activator of CFTR Cl
-
conductance in most epithelial cells (Gadsby and Nairn
1999). b-Adrenergic stimulation appears to act via the G
protein-coupled adenyl cyclase/cAMP cascade to stimulate
CFTR-mediated secretions in a number of exocrine glands
including sweat glands, airways and salivary glands
(Gadsby and Nairn 1999; Quinton 1999). Therefore, even
though CFTR can be activated by several agonists, cAMP/
PKA-dependent activation of CFTR may be the predomi-
nant intracellular mechanism responsible for maintaining
basal CFTR activity in most epithelial cells. Accepting this
notion leads to the question of why CFTR is subject to
regulation by so many different mechanisms in the same
tissue, as observed here. Part of the answer may lie in our
early observation that cAMP fails to fully activate gCFTR
in sweat ducts from some individuals (Reddy et al. 2008).
This may be due to strong endogenous activity of okadaic
acid-sensitive phosphatase, responsible for deactivating
PKA-phosphorylated CFTR or relatively weak PKA
activity resulting in minimal activation of CFTR channels
(Reddy et al. 2008). Cytosolic alkalinization (pH 8.5) was
shown to inhibit this phosphatase and stimulate PKA while
signiﬁcantly enhancing cAMP-stimulated gCFTR (Reddy
et al. 2008). Even though the mechanism underlying such
unusually small cAMP activation of CFTR is unknown at
this time, back-up mechanisms of stimulating CFTR by
alternative pathways such as the one mediated by G pro-
teins may provide critical protection of a signiﬁcant
physiological function of conserving salt during exercise.
This is particularly signiﬁcant in subjects with unusually
large okadaic acid-sensitive PP2A or weak PKA activity.
Furthermore, the mechanisms involved in the G protein
regulation of CFTR may be tissue-speciﬁc. Unlike in the
sweat ducts, where activating G proteins causes increased
CFTR channel function, heterotrimeric G proteins coupled
to adenosine receptors may downregulate CFTR in the
airways (Schwiebert et al. 1992).
The physiological signiﬁcance of cGMP regulation is
intriguing because this agonist activates CFTR in\50% of
the ducts. This observation suggests that cGMP regulation
is triggered by speciﬁc physiological situations that are not
deﬁned at this time. However, preliminary data indicated
that cGMP along with cytosolic glutamate seem to poten-
tiate HCO3
- conductance through CFTR (Reddy and
Quinton 2003, 2005a, 2008). Since cGMP appears to be the
predominant mechanism of regulating CFTR in the intes-
tinal epithelium, it seems possible that this speciﬁc regu-
latory mechanisms may be associated with a tissue-speciﬁc
function such as bicarbonate secretion to neutralize acid
(due to bacterial activity) or facilitate mucous secretion in
the gut, which needs further investigation.
Likewise, the exact physiological role of glutamate in
regulating CFTR anion channel function is unclear. How-
ever, it is an important intracellular osmolyte. Preliminary
evidence suggests that the glutamate regulatory mechanism
appears to be sensitive to changes in both luminal and
cytosolic Na
? concentration. Therefore, this regulatory
mechanism may help in the control of salt transport activity
at the apical membrane (Reddy and Quinton 2005b). In
addition, in the presence of ATP, glutamate seems to play a
signiﬁcant role in increasing the HCO3
- selectivity of
CFTR, which could have important implications for regu-
lating the pH of cytosolic as well as exocrine secretory
ﬂuids (Reddy and Quinton 2003).
Implications for Electrolyte Transport in CF
Even though it is well known that CFTR can be phos-
phorylation-activated by different kinases, it was unclear
whether these kinases phosphorylate common sites or dif-
ferent kinase-speciﬁc sites. The observation that okadaic
acid-sensitive phosphatase only dephosphorylates PKA but
not the G protein- and cGMP-dependent kinase-phos-
phorylated CFTR indicates that different endogenous
phosphatases speciﬁcally dephosphorylate distinct PKA, G
protein and cGMP-phosphorylated sites. Pharmacological
efforts to manipulate mutant CFTR activity in CF cells may
have to take into account this fact. That is, one must also
consider whether a given CF mutation affects just PKA and
not other (G protein and cGMP) mechanisms as well so
that they can be exploited as alternative modes of acti-
vating different mutant forms of CFTR. These results also
indicate that the phosphorylation-activated CFTR is deac-
tivated by depletion of cytosolic K
? regardless of the
kinase (i.e., G protein-activated kinase and PKG) involved
(Figs. 6, 9). Since cytosolic K
? activity appears to be a
function of transepithelial salt transport (Reddy and
Quinton 2006), therapeutic strategies aimed at manipulat-
ing salt transport to treat electrolyte transport disorder in
CF may have to consider potential changes in cytosolic
monovalent cation composition during chronic pharmaco-
logical treatments. For example, attempts to decrease Na
?
absorption by chronic amiloride treatment might increase
cytosolic K
? activity (Reddy and Quinton 1991, 2006), and
likewise pharmacological intervention to increase basolat-
eral K
? conductance to enhance electrical driving force for
Cl
- secretion (Schultz et al. 1999) may decrease cytosolic
K
? concentration (Sato et al. 1993; Suzuki et al. 1991;
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endogenous phosphorylation processes involving not only
CFTR but also other vital physiological functions in the
affected epithelial cells.
Conclusions
The CFTR Cl
- conductance in the native human sweat
duct is constitutively activated by PKA phosphorylation.
Different phosphatases appear to dephosphorylate PKA-, G
protein- and PKG-activated CFTR. Okadaic acid-sensitive
PP2A can only deactivate PKA but not G protein- and
cGMP-activated CFTR. PKA phosphorylation is sensitive
to cytosolic changes in monovalent cation composition
regardless of the kinase (PKA, PKG and G protein-acti-
vated kinase) involved. Therapeutic strategies aimed at
curing CF must take into account the fact that multiple
independent regulatory controls may exist within the same
tissue that can be exploited to activate different mutant
forms of CFTR.
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